Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism

Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases

Eusebi P.
Franchini D.
De Giorgi M.
Abraha I.
Montedori A.
Casucci P.
Calabresi P. (ORCID:0000-0003-0326-5509)
Tambasco N.

January 2019

Parkinson’s disease is known to pose a significant burden on society in industrialized countries. Ho...

Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with COVID-19 in a New York City Hospital System.

Nwabuobi, Lynda
Zhang, Cenai
Henchcliffe, Claire
Shah, Hiral
Sarva, Harini
Lee, Andrea
Kamel, Hooman

October 2021

BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has caused worse health outcomes among el...

Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown

Baschi R.
Luca A.
Nicoletti A.
Caccamo M.
Cicero C. E.
D'Agate C.
Di Giorgi L.
La Bianca G.
Lo Castro T.
Zappia M.
Monastero R.

December 2020

Objective: The effects of the COVID-19 lockdown on subjects with prodromal phases of dementia are un...

Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism

Vignatelli, Luca
Zenesini, Corrado
Belotti, Laura M B
Baldin, Elisa
Bonavina, Giuseppe
Calandra-Buonaura, Giovanna
Cortelli, Pietro
Descovich, Carlo
Fabbri, Giovanni
Giannini, Giulia
Guarino, Maria
Pantieri, Roberta
Samoggia, Giuseppe
Scaglione, Cesa
Trombetti, Susanna
D'Alessandro, Roberto
Nonino, Francesco

January 2021

The risk of COVID-19 and related death in people with Parkinson's disease or parkinsonism is uncerta...

Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study

Zenesini C.
Vignatelli L.
Belotti L. M. B.
Baccari F.
Calandra Buonaura G.
Cortelli P.
Descovich C.
Giannini G.
Guaraldi P.
Guarino M.
Loddo G.
Pantieri R.
Perlangeli V.
Scaglione C.
Stivanello E.
Trombetti S.
D'Alessandro R.
Baldin E.
Nonino F.
Azzoni E.
Baschieri F.
Bellan M.
Bettelli L.
Bonavina G.
Capellari S.
Cevoli S.
de Carolis P.
Di Diodoro D.
Fabbri G.
Ferrara R.
Gabellini A. S.
Lucchi F.
Mostacci B.
Procaccianti G.
Rinaldi R.
Rizzo G.
Sacquegna T.
Samoggia G.
Tempestini A.
Trocino C.

January 2022

Background and purpose: The patterns of long-term risk of SARS-CoV-2 infection, hospitalization for ...

The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study

Vignatelli, Luca
Baccari, Flavia
Belotti, Laura Maria Beatrice
Zenesini, Corrado
Baldin, Elisa
Calandra-Buonaura, Giovanna
Cortelli, Pietro
Descovich, Carlo
Giannini, Giulia
Guarino, Maria
Loddo, Giuseppe
Nassetti, Stefania Alessandra
Sambati, Luisa
Scaglione, Cesa
Trombetti, Susanna
D'Alessandro, Roberto
Nonino, Francesco

January 2022

BackgroundThe indirect impact of the COVID-19 epidemic on major clinical outcomes of people with Par...

COVID-19 and Parkinson's disease: what do we know so far?

Artusi, Carlo Alberto
Romagnolo, Albertoa
Ledda, Claudia
Zibetti, Maurizio
Rizzone, Mario Giorgio
Montanaro, Elisa
Bozzali, Marco
Lopiano, Leonardo

April 2021

Background: Many studies on Parkinson’s disease (PD) patients affected by Coronavirus-disease-2019 ...

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region

Del Prete E.
Francesconi A.
Palermo G.
Mazzucchi S.
Frosini D.
Morganti R.
Coleschi P.
Raglione L. M.
Vanni P.
Ramat S.
Novelli A.
Napolitano A.
Battisti C.
Giuntini M.
Rossi C.
Menichetti C.
Ulivelli M.
De Franco V.
Rossi S.
Bonuccelli U.
Ceravolo R.

January 2021

Background: If Parkinson’s Disease (PD) may represent a risk factor for Coronavirus disease 2019 (CO...

Data collection questionnaire.

Lexy Sorrell (15266813)
Valentina Leta (11242926)
Anton Barnett (16715438)
Kara Stevens (271937)
Angela King (11072601)
Jemma Inches (16715441)
Christopher Kobylecki (16715444)
Richard Walker (3126456)
K. Ray Chaudhuri (8967020)
Hannah Martin (7951622)
Jane Rideout (16715447)
J. Robert Sneyd (16715450)
Sarah Campbell (2466301)
Camille Carroll (6413720)

July 2023

BackgroundParkinson’s disease has been identified as a risk factor for severe Coronavirus disease 20...

Parkinson's disease related mortality: Long-term trends and impact of COVID-19 pandemic waves

Fedeli U.
Casotto V.
Barbiellini Amidei C.
Saia M.
Tiozzo S. N.
Basso C.
Schievano E.

January 2022

Introduction: Parkinson's disease (PD) mortality burden is increasing worldwide, but accurate estima...

Patient demographics by diagnosis.

Lexy Sorrell (15266813)
Valentina Leta (11242926)
Anton Barnett (16715438)
Kara Stevens (271937)
Angela King (11072601)
Jemma Inches (16715441)
Christopher Kobylecki (16715444)
Richard Walker (3126456)
K. Ray Chaudhuri (8967020)
Hannah Martin (7951622)
Jane Rideout (16715447)
J. Robert Sneyd (16715450)
Sarah Campbell (2466301)
Camille Carroll (6413720)

July 2023

BackgroundParkinson’s disease has been identified as a risk factor for severe Coronavirus disease 20...

The clinical impact of COVID-19 infection on people with Parkinson's

Hand, Annette
Chaudhuri, K Ray

June 2020

The impact of COVID-19 has been, and continues to be, felt across the world. For some people the ris...

The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.

Chiara Sorbera
Amelia Brigandì
Vincenzo Cimino
Lilla Bonanno
Rosella Ciurleo
Placido Bramanti
Giuseppe Di Lorenzo
Silvia Marino

January 2021

On March 2019 the World Health Organization declared Coronavirus disease (COVID-19) pandemic. Severa...

The impact of COVID-19 on access to Parkinson’s disease medication

Noyce, A

December 2020

Background: Many countries have implemented drastic measures to fight the COVID‐19 pandemic. Restri...

Covid-19 in Parkinson’s Disease treated by drugs or brain stimulation

Salari, Mehri
Etemadifar, Masoud
Zali, Alireza
Aminzade, Zahra
Navalpotro-Gómez, Irene
Fateh, Sepand Tehrani

January 2021

Data de publicació electrónica: 02-08-2021Purpose: Covid-19 has affected all people, especially thos...

Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases

Eusebi P.
Franchini D.
De Giorgi M.
Abraha I.
Montedori A.
Casucci P.
Calabresi P. (ORCID:0000-0003-0326-5509)
Tambasco N.

January 2019

Parkinson’s disease is known to pose a significant burden on society in industrialized countries. Ho...

Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with COVID-19 in a New York City Hospital System.

Nwabuobi, Lynda
Zhang, Cenai
Henchcliffe, Claire
Shah, Hiral
Sarva, Harini
Lee, Andrea
Kamel, Hooman

October 2021

BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has caused worse health outcomes among el...

Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown

Baschi R.
Luca A.
Nicoletti A.
Caccamo M.
Cicero C. E.
D'Agate C.
Di Giorgi L.
La Bianca G.
Lo Castro T.
Zappia M.
Monastero R.

December 2020

Objective: The effects of the COVID-19 lockdown on subjects with prodromal phases of dementia are un...

Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism

Vignatelli, Luca
Zenesini, Corrado
Belotti, Laura M B
Baldin, Elisa
Bonavina, Giuseppe
Calandra-Buonaura, Giovanna
Cortelli, Pietro
Descovich, Carlo
Fabbri, Giovanni
Giannini, Giulia
Guarino, Maria
Pantieri, Roberta
Samoggia, Giuseppe
Scaglione, Cesa
Trombetti, Susanna
D'Alessandro, Roberto
Nonino, Francesco

January 2021

The risk of COVID-19 and related death in people with Parkinson's disease or parkinsonism is uncerta...

Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study

Zenesini C.
Vignatelli L.
Belotti L. M. B.
Baccari F.
Calandra Buonaura G.
Cortelli P.
Descovich C.
Giannini G.
Guaraldi P.
Guarino M.
Loddo G.
Pantieri R.
Perlangeli V.
Scaglione C.
Stivanello E.
Trombetti S.
D'Alessandro R.
Baldin E.
Nonino F.
Azzoni E.
Baschieri F.
Bellan M.
Bettelli L.
Bonavina G.
Capellari S.
Cevoli S.
de Carolis P.
Di Diodoro D.
Fabbri G.
Ferrara R.
Gabellini A. S.
Lucchi F.
Mostacci B.
Procaccianti G.
Rinaldi R.
Rizzo G.
Sacquegna T.
Samoggia G.
Tempestini A.
Trocino C.

January 2022

Background and purpose: The patterns of long-term risk of SARS-CoV-2 infection, hospitalization for ...

The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study

Vignatelli, Luca
Baccari, Flavia
Belotti, Laura Maria Beatrice
Zenesini, Corrado
Baldin, Elisa
Calandra-Buonaura, Giovanna
Cortelli, Pietro
Descovich, Carlo
Giannini, Giulia
Guarino, Maria
Loddo, Giuseppe
Nassetti, Stefania Alessandra
Sambati, Luisa
Scaglione, Cesa
Trombetti, Susanna
D'Alessandro, Roberto
Nonino, Francesco

January 2022

BackgroundThe indirect impact of the COVID-19 epidemic on major clinical outcomes of people with Par...

COVID-19 and Parkinson's disease: what do we know so far?

Artusi, Carlo Alberto
Romagnolo, Albertoa
Ledda, Claudia
Zibetti, Maurizio
Rizzone, Mario Giorgio
Montanaro, Elisa
Bozzali, Marco
Lopiano, Leonardo

April 2021

Background: Many studies on Parkinson’s disease (PD) patients affected by Coronavirus-disease-2019 ...

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region

Del Prete E.
Francesconi A.
Palermo G.
Mazzucchi S.
Frosini D.
Morganti R.
Coleschi P.
Raglione L. M.
Vanni P.
Ramat S.
Novelli A.
Napolitano A.
Battisti C.
Giuntini M.
Rossi C.
Menichetti C.
Ulivelli M.
De Franco V.
Rossi S.
Bonuccelli U.
Ceravolo R.

January 2021

Background: If Parkinson’s Disease (PD) may represent a risk factor for Coronavirus disease 2019 (CO...

Data collection questionnaire.

Lexy Sorrell (15266813)
Valentina Leta (11242926)
Anton Barnett (16715438)
Kara Stevens (271937)
Angela King (11072601)
Jemma Inches (16715441)
Christopher Kobylecki (16715444)
Richard Walker (3126456)
K. Ray Chaudhuri (8967020)
Hannah Martin (7951622)
Jane Rideout (16715447)
J. Robert Sneyd (16715450)
Sarah Campbell (2466301)
Camille Carroll (6413720)

July 2023

BackgroundParkinson’s disease has been identified as a risk factor for severe Coronavirus disease 20...

Parkinson's disease related mortality: Long-term trends and impact of COVID-19 pandemic waves

Fedeli U.
Casotto V.
Barbiellini Amidei C.
Saia M.
Tiozzo S. N.
Basso C.
Schievano E.

January 2022

Introduction: Parkinson's disease (PD) mortality burden is increasing worldwide, but accurate estima...

Patient demographics by diagnosis.

Lexy Sorrell (15266813)
Valentina Leta (11242926)
Anton Barnett (16715438)
Kara Stevens (271937)
Angela King (11072601)
Jemma Inches (16715441)
Christopher Kobylecki (16715444)
Richard Walker (3126456)
K. Ray Chaudhuri (8967020)
Hannah Martin (7951622)
Jane Rideout (16715447)
J. Robert Sneyd (16715450)
Sarah Campbell (2466301)
Camille Carroll (6413720)

July 2023

BackgroundParkinson’s disease has been identified as a risk factor for severe Coronavirus disease 20...

The clinical impact of COVID-19 infection on people with Parkinson's

Hand, Annette
Chaudhuri, K Ray

June 2020

The impact of COVID-19 has been, and continues to be, felt across the world. For some people the ris...

The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.

Chiara Sorbera
Amelia Brigandì
Vincenzo Cimino
Lilla Bonanno
Rosella Ciurleo
Placido Bramanti
Giuseppe Di Lorenzo
Silvia Marino

January 2021

On March 2019 the World Health Organization declared Coronavirus disease (COVID-19) pandemic. Severa...

The impact of COVID-19 on access to Parkinson’s disease medication

Noyce, A

December 2020

Background: Many countries have implemented drastic measures to fight the COVID‐19 pandemic. Restri...

Covid-19 in Parkinson’s Disease treated by drugs or brain stimulation

Salari, Mehri
Etemadifar, Masoud
Zali, Alireza
Aminzade, Zahra
Navalpotro-Gómez, Irene
Fateh, Sepand Tehrani

January 2021

Data de publicació electrónica: 02-08-2021Purpose: Covid-19 has affected all people, especially thos...

Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases

Eusebi P.
Franchini D.
De Giorgi M.
Abraha I.
Montedori A.
Casucci P.
Calabresi P. (ORCID:0000-0003-0326-5509)
Tambasco N.

January 2019

Parkinson’s disease is known to pose a significant burden on society in industrialized countries. Ho...

Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with COVID-19 in a New York City Hospital System.

Nwabuobi, Lynda
Zhang, Cenai
Henchcliffe, Claire
Shah, Hiral
Sarva, Harini
Lee, Andrea
Kamel, Hooman

October 2021

BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has caused worse health outcomes among el...

Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown

Baschi R.
Luca A.
Nicoletti A.
Caccamo M.
Cicero C. E.
D'Agate C.
Di Giorgi L.
La Bianca G.
Lo Castro T.
Zappia M.
Monastero R.

December 2020

Objective: The effects of the COVID-19 lockdown on subjects with prodromal phases of dementia are un...

Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism

Abstract

Extracted data

Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism

Abstract

Extracted data

Topics

Related items

Topics

Related items